CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023
Cash Flows From Operating Activities:
Net income (loss)	$ 2,734	$ (6,399)
Adjustments to reconcile net income (loss) to net cash from operating activities:
Depreciation and amortization	5,745	7,532
Amortization of deferred debt issuance costs	2,484	2,719
Amortization and impairment of operating lease right of use assets	10,867	8,174
Non-cash share-based compensation	7,581	5,027
Loss on disposal or impairment of licenses, property and equipment, and software	308	381
Fair value adjustments on interest rate derivatives	(5,130)	1,738
Deferred income taxes	611	592
Changes in operating assets and liabilities, net of impact of acquisitions:
Patient accounts receivable	(36,404)	(16,195)
Prepaid expenses	1,032	1,354
Other current and long-term assets	(14,578)	(10,720)
Accounts payable and other accrued liabilities	8,362	(5,790)
Accrued payroll and employee benefits	5,464	16,347
Insurance reserves	7,365	(3,016)
Operating lease liabilities	(10,277)	(7,281)
Other current and long-term liabilities	3,673	2,514
Net cash used in operating activities	(10,163)	(3,023)
Cash Flows From Investing Activities:
Purchase of certificates of need		(2,678)
Purchases of property and equipment, and software	(2,577)	(3,421)
Net cash used in investing activities	(2,577)	(6,099)
Cash Flows From Financing Activities:
Proceeds from employee stock purchase plan	1,349	945
Proceeds from securitization obligation	25,000	45,000
Repayment of securitization obligation	(10,000)	(25,000)
Proceeds from revolving credit facility		20,000
Repayments on revolving credit facility		(20,000)
Principal payments on term loans	(4,600)	(4,600)
Principal payments on notes payable	(3,561)	(5,125)
Principal payments on financing lease obligations	(131)	(378)
Payment of debt issuance costs	(267)
Settlements with interest rate swap counterparties	8,669	7,075
Net cash provided by financing activities	16,459	17,917
Net change in cash and cash equivalents	3,719	8,795
Cash and cash equivalents at beginning of period	43,942	19,217
Cash and cash equivalents at end of period	47,661	28,012
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	77,232	60,631
Cash paid for income taxes, net of refunds received	$ 4,939	$ 158